Searchable abstracts of presentations at key conferences in endocrinology

ea0026oc1.4 | Thyroid/Adrenal | ECE2011

Results of 1,Ortho-1,para′-dichloro-diphenyl-dichloroethane (O,p′DDD) treatment in 76 patients with Cushing's disease

Baudry C , Coste J , Khalil R Bou , Guignat L , Abbas H , Guibourdenche J , Silvera S , Bertagna X , Bertherat J

Introduction: Alternative to transsphenoidal pituitary surgery (TSS) may be required in Cushing’s disease (CD), as first or second line treatment. 1,ortho-1,para′-dichloro-diphenyl-dichloroethane (o,p′DDD) has a potent anticortisolic action. Its place in CD treatment is not well defined. The aim of this study was to further evaluate the efficacy and tolerance of o,p′DDD in CD.Patients and m...

ea0073pep12.4 | Presented ePosters 12: Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Relationship between adiponectin, TNFα and SHBG in prepubertal children with obesity

Ramon-Krauel Marta , Leal-Witt Maria Jesus , Osorio-Conles Oscar , Amat-Bou Montse , Lerin Carles , Martinez David

Sex hormone-binding globulin levels are low in adult subjects with obesity when compared to normal-weight individuals. Obesity is associated with higher tumor necrosis factor alpha (TNFα) plasma levels and lower adiponectin levels. Moreover, we have recently elucidated the molecular mechanisms by which TNFα and adiponectin regulate hepatic SHBG production. The main objective of this study was to assess if the adult associations between TNFα, Adiponectin and SHBG...

ea0070aep912 | Thyroid | ECE2020

Thyroid arterial embolization for refractory amiodarone-induced thyrotoxicosis in a patient with congenital heart disease

Bouça Bruno , Cláudia Martins Ana , Bogalho Paula , de Sousa Lídia , Bilhim Tiago , Veloso Gomes Filipe , Coimbra Élia , Agapito Ana

Introduction: Amiodarone-induced thyrotoxicosis (AIT) in patients with congenital heart disease (CHD) has an estimated cumulative incidence of 13–21%, and prompt reversal to euthyroidism is crucial in these patients. We present a case of refractory AIT in a patient with CHD who was treated with thyroid arterial embolization (TAE).Clinical case: A 34-year-old male with complex cyanotic CHD (great vessels transposition, interventricular communication...

ea0026p252 | Pituitary | ECE2011

Initial management and complications of Cushing disease (CD): a French multicenter study of 437 patients

Baudry C , Martinie M , Fathallah-Sahnoun M , Gatta-Cherifi B , Khalil R Bou , Guignat L , Gay E , Raverot G , Brue T , Tabarin A , Chabre O , Bertherat J

Introduction: CD is a rare disease. Our aim was to describe demographic and clinical characteristics together with initial management of patients with CD.Patients and methods: A retrospective analysis of 437 CD patients diagnosed between 1996 and 2009, followed in 5 tertiary centers (Bordeaux, Grenoble, Lyon, Marseille, Paris) was performed in the frame of the national program for rare diseases.Results: 347 (80%) were women. Mean a...

ea0073aep115 | Calcium and Bone | ECE2021

Transient hypocalcaemia and definitive hypoparathyroidism after total thyroidectomy in Graves’ disease

Bruno Bouça , Amaral Sara , Vasques Miguel , Monteiro Nuno , Crespo Ana , José Coutinho , Tavares Paula , Bogalho Paula , José Silva-Nunes

IntroductionHypocalcaemia is a complication of total thyroidectomy (TT) and may be more frequent in patients with Graves’ disease. The reason for this increased risk is unclear and its occurrence has been associated with: ophthalmopathy severity, preoperative calcaemia and reimplantation of parathyroid glands.ObjectivesTo evaluate the risk factors for transient hypocalcaemia (TH) and definitive hypoparat...

ea0073aep246 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Risk factors associated with diabetic foot amputation among patients hospitalized for diabetic foot ulcer in a public hospital

Gutu Olga , Vasques Miguel , Inês Manique , Amaral Sara , Bruno Bouça , Prokop Joanna , Ana Cláudia Martins , António Afonso , José Neves , Silva-Nunes Jose

IntroductionDiabetic foot is one of the most devastating of chronic complications of diabetes mellitus (DM) and is responsible for about 25% of hospitalizations. Worldwide, the diabetic foot represents the main cause of non-traumatic lower limb amputation.Aim of the studyIdentification of risk factors for foot amputation among in patients hospitalized for diabetic foot in a tertiary public hospital in Portuga...

ea0099p2 | Adrenal and Cardiovascular Endocrinology | ECE2024

Prospective, multi-country, observational study of patients with endogenous Cushing’s syndrome exposed to Ketoconazole (using the existing European Registry on Cushing’s Syndrome (ERCUSYN)), to assess drug use, safety and effectiveness

Webb Susan , Santos Alicia , Aulinas Maso Anna , Tomsic Karin Zibar , Amaral Claudia , Feelders Richard , Ragnarsson Oskar , Ferrante Emanuele , Ceccato Filippo , Chabre Olivier , Cristante Justine , Hanzu Felicia , Reincke Martin , Chanson Philippe , Tabarin Antoine , Sequeira Duarte Joao , Guelho Daniela , Fajardo Carmen , Bostnavaron Martine , Bou Nader Myriam , Bertherat Jerome , Brue Thierry

Background: Ketoconazole is a steroidogenesis inhibitor approved in Europe for the treatment of endogenous Cushing’s syndrome (CS) based on retrospective studies published over 3 decades. We present interim data from the first prospective observational, multicenter, international study on ketoconazole, a non-interventional PASS (Post-Authorization Safety study) requested by EMA at the time of registration to confirm ketoconazole good tolerance and effectiveness. This stud...